McNeil AB

CompanySweden

McNeil AB develops one asset, approved (nicotine in smoking). Mostly small molecule acting on CHRNA4, CHRNB2 and CHRNA7; based in Sweden.

Assets
1
Furthest
Approved
Trials
8
Signals
0

Pipeline

1

  • nicotine

    Nicotinic acetylcholine receptor agonist

    ApprovedSmall moleculeCHRNA4CHRNB2smokingsmoking cessation

Full company profiles: pipeline, trials, funding and people.

See Pro
  • Evidence behind the mechanisms3
  • Trials10
  • Similar companies6

Updated 7 Oct 2026 · 32 sources

Intelligence